267 related articles for article (PubMed ID: 34006970)
1. Metformin treatment response is dependent on glucose growth conditions and metabolic phenotype in colorectal cancer cells.
Alhourani AH; Tidwell TR; Bokil AA; Røsland GV; Tronstad KJ; Søreide K; Hagland HR
Sci Rep; 2021 May; 11(1):10487. PubMed ID: 34006970
[TBL] [Abstract][Full Text] [Related]
2. Metformin is synthetically lethal with glucose withdrawal in cancer cells.
Menendez JA; Oliveras-Ferraros C; Cufí S; Corominas-Faja B; Joven J; Martin-Castillo B; Vazquez-Martin A
Cell Cycle; 2012 Aug; 11(15):2782-92. PubMed ID: 22809961
[TBL] [Abstract][Full Text] [Related]
3. Metformin Inhibits Cellular Proliferation and Bioenergetics in Colorectal Cancer Patient-Derived Xenografts.
Mohamed Suhaimi NA; Phyo WM; Yap HY; Choy SHY; Wei X; Choudhury Y; Tan WJ; Tan LAPY; Foo RSY; Tan SHS; Tiang Z; Wong CF; Koh PK; Tan MH
Mol Cancer Ther; 2017 Sep; 16(9):2035-2044. PubMed ID: 28533437
[TBL] [Abstract][Full Text] [Related]
4. High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells.
Varghese S; Samuel SM; Varghese E; Kubatka P; Büsselberg D
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30626087
[TBL] [Abstract][Full Text] [Related]
5. Metformin and Glucose Concentration as Limiting Factors in Retinal Pigment Epithelial Cell Viability and Proliferation.
Villa-Fernández E; García AV; Fernández-Fernández A; García-Villarino M; Ares-Blanco J; Pujante P; González-Vidal T; Fraga MF; Torre EM; Delgado E; Lambert C
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473884
[TBL] [Abstract][Full Text] [Related]
6. Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells.
Amaral I; Silva C; Correia-Branco A; Martel F
Biomed Pharmacother; 2018 Jun; 102():94-101. PubMed ID: 29550639
[TBL] [Abstract][Full Text] [Related]
7. Glucose promotes breast cancer aggression and reduces metformin efficacy.
Wahdan-Alaswad R; Fan Z; Edgerton SM; Liu B; Deng XS; Arnadottir SS; Richer JK; Anderson SM; Thor AD
Cell Cycle; 2013 Dec; 12(24):3759-69. PubMed ID: 24107633
[TBL] [Abstract][Full Text] [Related]
8. Metformin prevents DMH-induced colorectal cancer in diabetic rats by reversing the warburg effect.
Jia Y; Ma Z; Liu X; Zhou W; He S; Xu X; Ren G; Xu G; Tian K
Cancer Med; 2015 Nov; 4(11):1730-41. PubMed ID: 26376762
[TBL] [Abstract][Full Text] [Related]
9. Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells.
Karnevi E; Said K; Andersson R; Rosendahl AH
BMC Cancer; 2013 May; 13():235. PubMed ID: 23663483
[TBL] [Abstract][Full Text] [Related]
10. Butyrate and Metformin Affect Energy Metabolism Independently of the Metabolic Phenotype in the Tumor Therapy Model.
Meyer FB; Marx C; Spangel SB; Thierbach R
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944475
[TBL] [Abstract][Full Text] [Related]
11. Effects of metformin on CD133+ colorectal cancer cells in diabetic patients.
Zhang Y; Guan M; Zheng Z; Zhang Q; Gao F; Xue Y
PLoS One; 2013; 8(11):e81264. PubMed ID: 24278407
[TBL] [Abstract][Full Text] [Related]
12. Do MCF7 cells cope with metformin treatment under energetic stress in low glucose conditions?
Dogan Turacli I; Umudum H; Pampal A; Candar T; Kavasoglu L; Sari Y
Mol Biol Rep; 2018 Jun; 45(3):195-201. PubMed ID: 29397517
[TBL] [Abstract][Full Text] [Related]
13. Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions.
Silvestri A; Palumbo F; Rasi I; Posca D; Pavlidou T; Paoluzi S; Castagnoli L; Cesareni G
PLoS One; 2015; 10(8):e0136250. PubMed ID: 26291325
[TBL] [Abstract][Full Text] [Related]
14. Metabolic switching in the hypoglycemic and antitumor effects of metformin on high glucose induced HepG2 cells.
Lv Y; Tian N; Wang J; Yang M; Kong L
J Pharm Biomed Anal; 2018 Jul; 156():153-162. PubMed ID: 29705631
[TBL] [Abstract][Full Text] [Related]
15. Identification of glucose-independent and reversible metabolic pathways associated with anti-proliferative effect of metformin in liver cancer cells.
Islam SR; Manna SK
Metabolomics; 2024 Feb; 20(2):29. PubMed ID: 38413541
[TBL] [Abstract][Full Text] [Related]
16. Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis.
Griss T; Vincent EE; Egnatchik R; Chen J; Ma EH; Faubert B; Viollet B; DeBerardinis RJ; Jones RG
PLoS Biol; 2015 Dec; 13(12):e1002309. PubMed ID: 26625127
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic mechanisms underlying antidiabetic drug metformin's chemopreventive effect against colorectal cancer.
Jaromy M; Miller JD
Eur J Pharmacol; 2021 Apr; 897():173956. PubMed ID: 33617821
[TBL] [Abstract][Full Text] [Related]
18. Metformin inhibition of mTORC1 activation, DNA synthesis and proliferation in pancreatic cancer cells: dependence on glucose concentration and role of AMPK.
Sinnett-Smith J; Kisfalvi K; Kui R; Rozengurt E
Biochem Biophys Res Commun; 2013 Jan; 430(1):352-7. PubMed ID: 23159620
[TBL] [Abstract][Full Text] [Related]
19. Rewired Cellular Metabolic Profiles in Response to Metformin under Different Oxygen and Nutrient Conditions.
Liu S; Washio J; Sato S; Abiko Y; Shinohara Y; Kobayashi Y; Otani H; Sasaki S; Wang X; Takahashi N
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055173
[TBL] [Abstract][Full Text] [Related]
20. A new contribution for an old drug: Prospect of metformin in colorectal oncotherapy.
Jiang S; Lu Q
J Cancer Res Ther; 2021 Dec; 17(7):1608-1617. PubMed ID: 35381729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
